Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(29%)
Results Posted
200%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
1
14%
Ph phase_4
4
57%
Ph early_phase_1
1
14%
Ph not_applicable
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(1)
Terminated(2)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1
Terminated1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 44 (57.1%)
N/A1 (14.3%)

Trials by Status

completed114%
recruiting114%
terminated114%
unknown229%
withdrawn114%
active_not_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7